'GIOTRIFF' (apatinib): analogues, price. Where to buy Gyrotrif cheaper?

"Giotrif" - a drug that is often included in the scheme of treatment of non-small cell lung cancer. The active substance of the drug - afatinib - suppresses thyroxine kinase and thereby triggers the tumor regression process. The specificity of the drug is a selective effect on the ErbB receptors. In this connection, "Giotrip" is shown to patients with forms of cancer caused by mutations of EGFR.

Patients taking the drug noted good tolerability and high efficacy of the drug. The only drawback that has "Giotrif" is the price. It is quite high. In pharmacies in Moscow, tablets can be bought at a price ranging from 45 000 to 139 000 rubles (this variation in prices is due to the difference in dosage of the drug). However, you can buy a medicine at a lower price.

Where to buy "Giotrify"?

Buy the drug necessary for treatment, you can on the site WWW.ONKO24.COM . Here, "Giotrif" is sold at a significantly lower price. The thing is that you will be offered a generic version of the original German drug. It has the same high efficiency, in spite of the fact that in this case "Giotrief" can be bought cheaper. And the secret of a lower cost is that a drug is produced in India by a company that has received the appropriate license. The manufacturer does not spend money on clinical trials, because they have already been conducted. It does not form a budget for an advertising campaign, and it also reduces the final cost of the drug.

To order "Giotrif" on the website of an Indian company with five years of experience, you need to have documents confirming that you really need treatment with this medicine.

How to take "Giotrif": instructions

It is recommended to take medication on an empty stomach. It is advisable to do this about an hour before the next meal or three hours after the previous meal.

"Gitrif" is taken orally once a day. The tablet should be washed down with plenty of water.

The recommended dose is 40 mg per day. In cases where the drug is well tolerated, the doctor may decide to increase the dosage to 50 mg per day. However, this is the limit, which is prohibited in all clinical cases.

Adverse Reactions

Receiving "Gyotrif" can cause the following undesirable manifestations:

• Diarrhea, nausea, dyspepsia;
• Impaired kidney function;
• Decreased appetite;
• dehydration;
• Dry skin, dermatitis;
• Dryness and redness of the eyes;
• A violation of taste sensitivity.

Application in pregnancy and lactation

Appropriate clinical trials on humans have not been carried out, however, the use of the agent in female animals has not caused teratogenic effects.

Despite this, the use of the drug for the treatment of pregnant women and breastfeeding mothers is not recommended. If, during use in the scheme of treatment of the drug "Giotrip" a woman has a pregnancy, the patient should be warned about the possible negative effect of apathinib on the fetus.